Fresenius Medical Care Ag & CO Kgaa
Fresenius Medical Care Ag & CO Kgaa (FME.D) on the XETR Exchange
Company overview
Fresenius Medical Care Ag & CO Kgaa is a publicly listed company from Germany with shares traded on XETR under the ticker FME.D. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for FME.D are bid 39.999 USD and ask 40.081 USD.
Use the chart to review recent momentum, identify key price areas, and track how Fresenius Medical Care Ag & CO Kgaa is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add FME.D to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.
Key facts
- Exchange: XETR
- Company: Fresenius Medical Care Ag & CO Kgaa
- Ticker: FME.D
- Country: Germany
- Bid: 39.999 USD
- Ask: 40.081 USD
- Quotes: real-time, auto-updated
Risk
Risk Warning: Past performance of FME.D does not predict future returns.
FAQ
Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Fresenius Medical Care Ag & CO Kgaa (FME.D) in R StocksTrader. Create and verify your profile, fund the account, search for FME.D, and choose the instrument type available to you. Add FME.D to your Watchlist to track moves and manage open positions throughout 2025.
FME.D trades on XETR and is issued by Fresenius Medical Care Ag & CO Kgaa. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for FME.D match your plan.
Quotes update automatically in real time. Current levels for FME.D are bid 39.999 USD and ask 40.081 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track FME.D in R StocksTrader and adjust your approach as market conditions change in 2025.